Fate Therapeutics
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -21.83 | -100% |
| P/S |
|
5.3 | 33.76 | -84.31% |
|
|
| P/BV |
|
0.9135 | 4.82 | -81.05% |
|
|
| P/FCF |
|
-1.98 | 61 | -103.25% |
|
|
| Ev/Ebitda |
|
-2.5 | -22.15 | -88.72% |
|
|
| Ev/S |
|
6.27 | 22.56 | -72.22% |
|
|
| Ev/FCF |
|
-2.88 | 68.78 | -104.18% |
|
|
| E/P |
|
-0.5873 | 0.0178 | -3404.32% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-250.78 | 4.98 | -5138.87% | -453.13 | -44.66% |
| ROE |
|
-43.68 | 9.61 | -554.46% |
|
|
| ROA |
|
-31.79 | 0.3443 | -9334.41% |
|
|
| ROIC |
|
-28.41 | 7.63 | -472.13% |
|
|
| ROS |
|
-253.3 | -25.17 | 906.35% |
|
|
| ROCE |
|
-48.21 | 15.35 | -414.06% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.6498 | -3.68 | -82.32% | -0.5657 | +14.87% |
| Nеt Debt/Ebitda |
|
-0.387 | -3.44 | -88.74% |
|
|
| Debt/Ratio |
|
0.2045 | 0.1985 | 3.05% |
|
|
| Debt/Equity |
|
0.2062 | 1.66 | -87.59% |
|
|
| Debt/Net Income |
|
-0.6434 | 10.32 | -106.23% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5442 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2237 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9889 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4952 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5442 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
493.77 | -56.89 | -967.94% | ||
| Growth impulse Ebitda in 5 years |
|
78.66 | -54.68 | -243.86% | ||
| Growth impulse Net Income in 5 years |
|
67.63 | -58.33 | -215.94% | ||
| Growth impulse FCF in 5 years |
|
52.78 | -49.48 | -206.67% | ||
| Growth impulse EPS in 5 years |
|
15.98 | -32.41 | -149.31% |
IP Score
4.47/10
